Table 2.

Comparison Between 3036 Cases of Urogenital Tuberculosis From Developed Countries and 5925 Cases From Other Countries

Variable	Developed Countries	Other Countries	P Value*	Total
Total (N)	3036	5925		8961
Men	62.9	65.4	.02	64.9
Women	37.1	34.6	.02	35.1
Age (years), median (range)	42.6 (7–88)	39.2 (5–83)		40.7 (5–88)
Previous tuberculosis	37.9	38.4	.66	36.5
Symptoms and signs
Storage symptoms	44.2	55.2	<.01	50.5
Dysuria	33.8	46.4	<.01	37.9
Lumbar pain	28.8	42.3	<.01	34.4
Hematuria	24.5	44.3	<.01	35.6
Epididymis lesion†	20.6	47.4	<.01	48.9
Fever and malaise	23.2	19.9	.28	21.9
No symptoms	8.4	0	<.01	6.4
Renal failure	1.4	10.2	<.01	5.7
Diagnosis
Urine	79.0	55.4	<.01	64.2
Histopathology	7.8	38.3	<.01	21.9
Clinicoradiographic	9.6	11.3	.36	10.4
Kidney
Unilateral nonfunctioning	22.8	33.1	<.01	26.9
Normal	18.8	13.2	<.01	15.2
Contracted bladder	4.0	11.6	<.01	8.9
Surgeries	56.6	53.6	<.01	54.9
Ablative	35.0	26.9	<.01	27.2
Nephrectomy	27.9	26.0	.37	27.6

Developed countries included the United States, Japan, and those in Europe. Other countries included Russia and those in Latin America and Africa.

Values are percentages unless otherwise noted.

^*Comparison between developed countries and other countries (χ² test).

^†In relation to male patients.